• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本致死性骨发育不全患病率及预后的全国性调查。

National survey of prevalence and prognosis of thanatophoric dysplasia in Japan.

作者信息

Sawai Hideaki, Oka Kaname, Ushioda Mariko, Nishimura Gen, Omori Takashi, Numabe Hironao, Kosugi Shinji

机构信息

Department of Obstetrics and Gynecology, Hyogo College of Medicine, Nishinomiya, Japan.

Genetic Counsellor Course, Kyoto University School of Public Health, Kyoto, Japan.

出版信息

Pediatr Int. 2019 Aug;61(8):748-753. doi: 10.1111/ped.13927. Epub 2019 Aug 27.

DOI:10.1111/ped.13927
PMID:31247124
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6852317/
Abstract

BACKGROUND

Thanatophoric dysplasia (TD) is a rare congenital disease of the skeletal system, with an incidence of 1.68-8.3 per 100 000 births, but statistical data on the estimated number of TD patients across Japan are not available. The aim of this study was therefore to investigate the prevalence and prognosis of TD in Japan.

METHODS

A nationwide primary questionnaire survey was conducted.

RESULTS

A total of 127 obstetric, 186 pediatric, and 115 orthopedic facilities provided responses. Excluding duplications, we identified 73 patients with TD. Of the 73 cases, 15 were abortions, four were stillbirths, 51 were live births, and three had unknown details. Of the 51 live newborns, 27 died ≤7 days after birth, with an early neonatal mortality rate of 56%. Of the 24 newborns who survived the early neonatal period, 16 survived for ≥1 year. All of the 24 newborns received respiratory management and survived during the early neonatal period. Of the 51 live newborns, 25 did not receive respiratory management and died ≤2 days after birth.

CONCLUSIONS

The prevalence of TD in Japan is estimated to be at 1.1 (95%CI: 0.84-1.37) per 100 000 births, but the actual incidence is expected to be higher. To our knowledge, we have confirmed for the first time that newborns with TD may not always die during the early neonatal period but can survive the early neonatal period with appropriate respiratory management. Therefore, the term "thanatophoric dysplasia" does not accurately reflect the nature of the disease.

摘要

背景

致死性骨发育不全(TD)是一种罕见的先天性骨骼系统疾病,每10万例出生中发病率为1.68 - 8.3例,但日本全国TD患者估计数量的统计数据并不存在。因此,本研究的目的是调查日本TD的患病率和预后情况。

方法

进行了一项全国范围的初步问卷调查。

结果

共有127家产科机构、186家儿科机构和115家骨科机构提供了回复。排除重复病例后,我们确定了73例TD患者。在这73例病例中,15例为流产,4例为死产,51例为活产,3例情况不明。在51例活产新生儿中,27例在出生后≤7天死亡,早期新生儿死亡率为56%。在24例度过早期新生儿期的新生儿中,16例存活≥1年。所有24例新生儿均接受了呼吸管理并在早期新生儿期存活。在51例活产新生儿中,25例未接受呼吸管理并在出生后≤2天死亡。

结论

日本TD的患病率估计为每10万例出生中有1.1例(95%置信区间:0.84 - 1.37),但实际发病率预计更高。据我们所知,我们首次证实TD新生儿并非总是在早期新生儿期死亡,而是通过适当的呼吸管理可以在早期新生儿期存活。因此,“致死性骨发育不全”这一术语并不能准确反映该疾病的本质。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14cf/6852317/3e5958522c7c/PED-61-748-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14cf/6852317/e8a88f281a27/PED-61-748-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14cf/6852317/ebabdcdef511/PED-61-748-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14cf/6852317/3e5958522c7c/PED-61-748-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14cf/6852317/e8a88f281a27/PED-61-748-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14cf/6852317/ebabdcdef511/PED-61-748-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14cf/6852317/3e5958522c7c/PED-61-748-g003.jpg

相似文献

1
National survey of prevalence and prognosis of thanatophoric dysplasia in Japan.日本致死性骨发育不全患病率及预后的全国性调查。
Pediatr Int. 2019 Aug;61(8):748-753. doi: 10.1111/ped.13927. Epub 2019 Aug 27.
2
Development of individuals with thanatophoric dysplasia surviving beyond infancy.存活至婴儿期后的致死性骨发育不全患儿的个体发育
Pediatr Int. 2022 Jan;64(1):e15007. doi: 10.1111/ped.15007.
3
The prevalence of thanatophoric dysplasia and lethal osteogenesis imperfecta type II in Northern Ireland - a complete population study.北爱尔兰致死性发育不良和II型致死性成骨不全的患病率——一项全人群研究。
Ulster Med J. 2010 Sep;79(3):114-8.
4
Nationwide epidemiological survey of holoprosencephaly in Japan.日本全国家族性无脑回畸形的流行病学调查。
Pediatr Int. 2020 May;62(5):593-599. doi: 10.1111/ped.14135.
5
The population-based prevalence of achondroplasia and thanatophoric dysplasia in selected regions of the US.美国特定地区基于人群的软骨发育不全和致死性骨发育不良患病率。
Am J Med Genet A. 2008 Sep 15;146A(18):2385-9. doi: 10.1002/ajmg.a.32485.
6
Histopathology of the temporal bones in thanatophoric dysplasia.
Med J Osaka Univ. 1991 Mar;40(1-4):51-7.
7
Camptomelic dysplasia: a case study.
Neonatal Netw. 1999 Mar;18(2):41-8. doi: 10.1891/0730-0832.18.2.41.
8
Chylous Ascites in an Infant with Thanatophoric Dysplasia Type I with FGFR3 Mutation Surviving Five Months.一名患有I型致死性发育异常且伴有FGFR3突变的婴儿出现乳糜性腹水,存活了五个月。
Fetal Pediatr Pathol. 2018 Oct;37(5):363-371. doi: 10.1080/15513815.2018.1504843. Epub 2018 Sep 25.
9
Congenital limb deficiency in Japan: a cross-sectional nationwide survey on its epidemiology.日本的先天性肢体缺损:一项关于其流行病学的全国性横断面调查。
BMC Musculoskelet Disord. 2018 Jul 27;19(1):262. doi: 10.1186/s12891-018-2195-3.
10
The birth prevalence rates for the skeletal dysplasias.骨骼发育异常的出生患病率
J Med Genet. 1986 Aug;23(4):328-32. doi: 10.1136/jmg.23.4.328.

引用本文的文献

1
Thanatophoric Dysplasia: A Report of 2 Cases with Antenatal Misdiagnosis.致死性骨发育不全:2例产前误诊报告。
Case Rep Pediatr. 2022 Sep 28;2022:3056324. doi: 10.1155/2022/3056324. eCollection 2022.
2
Should We Stop Calling Thanatophoric Dysplasia a Lethal Condition? A Case Report of a Long-Term Survivor.我们是否应该停止将致死性骨发育不全称为致命病症?一例长期存活者的病例报告。
Palliat Med Rep. 2020 May 14;1(1):32-39. doi: 10.1089/pmr.2020.0016. eCollection 2020.
3
Fatal fetal abnormality Irish live-born survival-an observational study.

本文引用的文献

1
A Case of Thanatophoric Dysplasia Type I with Fetal Hydrops in the First Trimester.孕早期1型致死性骨发育不全合并胎儿水肿1例。
Case Rep Obstet Gynecol. 2016;2016:1821230. doi: 10.1155/2016/1821230. Epub 2016 Feb 23.
2
Growth and development in thanatophoric dysplasia - an update 25 years later.致死性骨发育不良的生长与发育——25年后的最新进展
Clin Case Rep. 2013 Dec;1(2):75-8. doi: 10.1002/ccr3.29. Epub 2013 Nov 15.
3
Clinical epidemiology of skeletal dysplasias in South America.南美洲骨骼发育不良的临床流行病学。
致命性胎儿异常:爱尔兰活产儿生存情况——一项观察性研究
J Community Genet. 2021 Oct;12(4):643-651. doi: 10.1007/s12687-021-00534-3. Epub 2021 Jul 2.
Am J Med Genet A. 2012 May;158A(5):1038-45. doi: 10.1002/ajmg.a.35246. Epub 2012 Mar 9.
4
The prevalence of thanatophoric dysplasia and lethal osteogenesis imperfecta type II in Northern Ireland - a complete population study.北爱尔兰致死性发育不良和II型致死性成骨不全的患病率——一项全人群研究。
Ulster Med J. 2010 Sep;79(3):114-8.
5
Seborrhoeic keratoses and acanthosis nigricans in a long-term survivor of thanatophoric dysplasia.致死性骨发育不良长期存活者的脂溢性角化病和黑棘皮病
Br J Dermatol. 2010 Sep;163(3):656-8. doi: 10.1111/j.1365-2133.2010.09879.x. Epub 2010 May 28.
6
Prenatal diagnosis of thanatophoric dysplasia by 3-D helical computed tomography and genetic analysis.
Fetal Diagn Ther. 2008;24(4):420-4. doi: 10.1159/000170092. Epub 2008 Nov 6.
7
The population-based prevalence of achondroplasia and thanatophoric dysplasia in selected regions of the US.美国特定地区基于人群的软骨发育不全和致死性骨发育不良患病率。
Am J Med Genet A. 2008 Sep 15;146A(18):2385-9. doi: 10.1002/ajmg.a.32485.
8
Prenatal diagnosis of thanatophoric dysplasia by mutational analysis of the fibroblast growth factor receptor 3 gene and a proposed correction of previously published PCR results.
Prenat Diagn. 1999 Jan;19(1):21-4. doi: 10.1002/(sici)1097-0223(199901)19:1<21::aid-pd457>3.0.co;2-5.
9
Long-term survival in typical thanatophoric dysplasia type 1.典型1型致死性骨发育不全的长期存活情况
Am J Med Genet. 1997 Jun 27;70(4):427-36.
10
Japanese cases of type 1 thanatophoric dysplasia exclusively carry a C to T transition at nucleotide 742 of the fibroblast growth factor receptor 3 gene.日本的1型致死性骨发育不全病例在成纤维细胞生长因子受体3基因的第742位核苷酸处均发生了C到T的转变。
Biochem Biophys Res Commun. 1996 Oct 3;227(1):236-9. doi: 10.1006/bbrc.1996.1495.